OEM News

FDA OKs Casio’s DERMOCAMERA and Scope for Skin Observation

To be available in the U.S. by March 2022.

Casio America has gained U.S. Food and Drug Administration (FDA) clearance for its DZ-D100 DERMOCAMERA and DZ-S50 scope for skin observation. They will be available on the company’s e-commerce site by March.
 
DZ-D100 has been available in Japan since May 2019. Developed with dermatology professionals, it allows standard sized and close-up shots of an affected area with one unit. Free downloadable software can be used to manage captured images.


DZ-S50 dermoscope.
 
The DZ-S50 scope was released in March 2020. Standard and close-up shots can be taken without switching lenses, and the unit also captures non-polarized and UV photos at the same viewpoint. Both devices launched in Australia and New Zealand in February 2021.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters